NKE
NIKE, Inc.
NKE offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
PHIN
PHINIA Inc.
PHIN has the edge over NKE overall, supported by stronger modeled upside and stronger fundamentals.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
PHIN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
PHIN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over PHIN in the historical PE scenario, which offers more potential upside but is not a forecast.
PHIN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 10x | $72.51 | — |
| Current | 15x | $72.51 | — |
| Cheap | 19x | $92.38 | +27% |
| Fair | 22x | $110 | +52% |
| Expensive | 25x | $121 | +67% |
Historical ranges are pointers, not guarantees.
PHIN's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
PHIN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
PHIN has the edge over NKE on the outlook, with more favorable valuation and earnings expectations.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
PHIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.94 | +40% |
| Q3 2026 | $4.95 | +122% |
| Q2 2026 | $3.48 | +34% |
| Q1 2026 | $3.57 | +102% |
| Q4 2025 | $3.24 | +84% |
| Q3 2025 | $2.23 | -4.3% |
| Q2 2025 | $2.60 | +39% |
| Q1 2025 | $1.77 | -23% |
| Q4 2024 | $1.76 | -15% |
PHIN has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
PHIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $912M | +0.4% |
| Q2 2026 | $940M | +5.6% |
| Q1 2026 | $878M | +10% |
| Q4 2025 | $889M | +6.7% |
| Q3 2025 | $908M | +8.2% |
| Q2 2025 | $890M | +2.5% |
| Q1 2025 | $796M | -7.8% |
| Q4 2024 | $833M | -5.6% |
PHIN has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.2% | +5.5 points |
| Q2 2026 | 8.5% | -1.5 points |
| Q1 2026 | 7.9% | +0.1 points |
| Q4 2025 | 7.8% | +1.6 points |
| Q3 2025 | 3.7% | -4.1 points |
| Q2 2025 | 10% | +1.8 points |
| Q1 2025 | 7.8% | -0.4 points |
| Q4 2024 | 6.1% | -3.1 points |
PHIN has the edge over NKE on profitability, with a higher operating margin.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
PHIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $70M | -25% |
| Q2 2026 | $69M | +200% |
| Q1 2026 | $21M | +320% |
| Q4 2025 | $67M | +26% |
| Q3 2025 | $93M | +33% |
| Q2 2025 | $23M | -75% |
| Q1 2025 | $5M | +$17M |
| Q4 2024 | $53M | +83% |
PHIN has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
PHIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -900K shares |
| 1 year | -6.3% | -2.5M shares |
| 3 years | -21% | -10M shares |
PHIN has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over PHIN on leverage, with a lower net debt burden relative to earnings.
PHIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.2x | Healthy |
PHIN's net debt is about 1.4 years of its operating earnings (EBITDA), down from 1.6 years a year ago.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
PHIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.2 | Neutral |
| Stochastic | 55.5 | Neutral |
PHIN's weekly RSI is 56 (neutral) and its Stochastic is 55 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
PHIN PE vs Consumer Cyclical Sector
| Metric | PHIN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 19% below |
| PE % | 1 | 35 | 34 pts below |
PHIN has the edge over NKE on valuation relative to its sector.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
PHIN has stronger trend alignment. NKE is above 1 of 5 weekly averages versus PHIN above 4 of 4.
PHIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.4 | 16% above |
| 20 week MA | $68.6 | 5.6% above |
| 50 week MA | $70.2 | 3.3% above |
| 100 week MA | $59.6 | 22% above |
PHIN is in an uptrend: it's above all four of its weekly moving averages, and 22% above its 100-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
PHIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $31.5 | $30.3 | -3.8% |
| 2024 | $30.3 | $48.2 | +59% |
| 2025 | $48.2 | $61.4 | +27% |
| 2026 YTD | $61.4 | $72.5 | +18% |
PHIN has the edge over NKE on returns for 2026, with the stronger performance.